Filing search / 1993-2019 / Teva Pharmaceutical Industries Limited / Page 37

6-K

alxnagftznma398tq

3 Oct 13

Teva Announces Favorable Ruling on Copaxone Patent Litigation In the Netherlands

12:00am

6-K

z95bgdry3hgjvy xdeo

3 Oct 13

Teva to Present Further Results of Twenty-year Open-label Extension Study of Glatiramer Acetate 20 MG Daily for Relapsing-remitting Multiple Sclerosis

12:00am

6-K

804tgu21nczi wli4

1 Oct 13

Teva Announces Launch of Generic Zemplar® In the United States

12:00am

6-K

s7lu2qep

1 Oct 13

Live Filing

12:00am

6-K

fy96z95v

30 Sep 13

Live Filing

12:00am

6-K

zijged0 k5

26 Sep 13

Live Filing

12:00am

6-K

dyr8lrn ro8c5lg

24 Sep 13

Teva Announces Exclusive Launch of Generic Adenoscan® In the United States

12:00am

6-K

5asynt5xroirp4v

23 Sep 13

Teva Announces Favorable Court Ruling In Azilect® Patent Infringement Litigation Against Mylan

12:00am

6-K

xb697qcqdwrhmr3wvs

20 Sep 13

Teva Announces Exclusive Launch of Generic Niaspan® In the United States

12:00am

6-K

chbt0xof

17 Sep 13

Fda Approves Teva’s Treanda® (Bendamustine Hci) Injection, a New Liquid Formulation

12:00am

6-K

so1blicmy4q cvp

16 Sep 13

Live Filing

12:00am

6-K

cwumpl

30 Aug 13

Live Filing

12:00am

6-K

pbjarmbf9kq

27 Aug 13

Live Filing

12:00am

6-K

s1mu328tzoi3w8w

14 Aug 13

Live Filing

12:00am

6-K

zjtq1ohldtu2 wmg3c

12 Aug 13

Teva Pharmaceuticals and Perrigo Company Announce the U.s. Launch of Generic Temozolomide

12:00am

6-K

3nnpi

8 Aug 13

Live Filing

12:00am

6-K

m9j4livingftl bg

7 Aug 13

Teva Pharmaceutical Industries Limited 6-K

12:00am

6-K

xevienrae0

1 Aug 13

Current report (foreign)

12:00am

6-K

89n88rkybebfb

1 Aug 13

Teva Reports Second Quarter 2013 Results

12:00am

6-K

cwy311h5vws

29 Jul 13

English Court of Appeal finds in favor of Teva on Copaxone® patent litigation and upholds validity of Copaxone patent until May 2015

12:00am